Page last updated: 2024-10-31

midodrine and Adenocarcinoma, Basal Cell

midodrine has been researched along with Adenocarcinoma, Basal Cell in 1 studies

Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liou, DZ1
Warren, H1
Maher, DP1
Soukiasian, HJ1
Melo, N1
Salim, A1
Ley, EJ1

Other Studies

1 other study available for midodrine and Adenocarcinoma, Basal Cell

ArticleYear
Midodrine: a novel therapeutic for refractory chylothorax.
    Chest, 2013, Volume: 144, Issue:3

    Topics: Adenocarcinoma; Chylothorax; Esophageal Neoplasms; Esophagectomy; Female; Follow-Up Studies; Humans;

2013